JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butler, T. C.
Right arrow Articles by Waddell, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butler, T. C.
Right arrow Articles by Waddell, W. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 127, Issue 3, 171-174, 1959
Copyright © 1959 by American Society for Pharmacology and Experimental Therapeutics


THE METABOLIC FATE OF 5-ETHYL-1-METHYL-5-PHENYL HYDANTOIN (1-METHYLNIRVANOL) AND THAT OF 3,5-DIETHYL-5-PHENYL HYDANTOIN (3-ETHYLNIRVANOL)

Thomas C. Butler 1 and William J. Waddell 1

1 Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

The metabolic fate in the dog of 5-ethyl-1-methyl-5-phenyl hydantoin (1-methylnirvanol) and that of 3,5-diethyl-5-phenyl hydantoin (3-ethylnirvanol) have been investigated.

Both of these compounds are in part dealkylated to yield 5-ethyl-5-phenyl hydantoin (Nirvanol), which has been isolated from urine and identified. The Nirvanol isolated from urine consisted of unequal mixtures of the optical isomers. The preponderant isomer after administration of Nirvanol was levorotatory, after 3-ethylnirvanol dextrorotatory, and after 1-methylnirvanol dextrorotatory in one dog and levorotatory in another.

The amount of Nirvanol isolated from urine was much smaller after administration of the 1-methyl and 3-ethyl derivatives of Nirvanol than after administration of Nirvanol itself. It was concluded that these derivatives of Nirvanol, unlike Mesantoin (3-methylnirvanol), are only in part converted to Nirvanol and that they undergo reactions other than dealKylation.

Submitted on June 1, 1959







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1959 by the American Society for Pharmacology and Experimental Therapeutics.